How have the companies the Houston Technology Center has worked with changed over the past decade?
We have the privilege of working with sets of companies as an incubator accelerator. Some started out from universities as just innovations, and some are involved with the Emerging Technology Fund. We’re now in 30 counties. So we’re a lot deeper than we were in 1999. And we’re seeing new models. Many of the companies are virtual. We are still bullish on medical devices because the models are closer to what investors are comfortable with. They don’t have to wait 18 to 19 years for development of a drug. It’s quicker to market and has a shorter regulatory path. Q: How is Houston’s life science sector seen by investors outside of Houston? A: We’re catching attention. I recently was able to hear Jacqueline Northcut of BioHouston, and her comments were that people are taking calls. We are getting individuals that are attending the conferences from all over now. The Texas Life Science Conference going on next week (Wednesday-Friday at Rice University) will be a major draw for investors. It’s
